Seguir
Ben J. Boyd
Título
Citado por
Citado por
Año
Minimum information reporting in bio–nano experimental literature
M Faria, M Björnmalm, KJ Thurecht, SJ Kent, RG Parton, M Kavallaris, ...
Nature nanotechnology 13 (9), 777-785, 2018
5202018
Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems
BJ Boyd, DV Whittaker, SM Khoo, G Davey
International journal of pharmaceutics 309 (1-2), 218-226, 2006
3682006
Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure
YD Dong, I Larson, T Hanley, BJ Boyd
Langmuir 22 (23), 9512-9518, 2006
3502006
Stimuli responsive liquid crystals provide ‘on-demand’drug delivery in vitro and in vivo
WK Fong, T Hanley, BJ Boyd
Journal of Controlled Release 135 (3), 218-226, 2009
3342009
Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersions
X Mulet, BJ Boyd, CJ Drummond
Journal of colloid and interface science 393, 1-20, 2013
3172013
Characterisation of drug release from cubosomes using the pressure ultrafiltration method
BJ Boyd
International journal of pharmaceutics 260 (2), 239-247, 2003
3012003
Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation
CJH Porter, AM Kaukonen, BJ Boyd, GA Edwards, WN Charman
Pharmaceutical research 21, 1405-1412, 2004
2892004
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems
BJ Boyd, CAS Bergström, Z Vinarov, M Kuentz, J Brouwers, P Augustijns, ...
European Journal of Pharmaceutical Sciences 137, 104967, 2019
2872019
Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine
CJH Porter, AM Kaukonen, A Taillardat-Bertschinger, BJ Boyd, ...
Journal of pharmaceutical sciences 93 (5), 1110-1121, 2004
2412004
Peptide-based biosensors
Q Liu, J Wang, BJ Boyd
Talanta 136, 114-127, 2015
2332015
Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations
AM Kaukonen, BJ Boyd, CJH Porter, WN Charman
Pharmaceutical research 21, 245-253, 2004
2272004
Evaluating the link between self-assembled mesophase structure and drug release
S Phan, WK Fong, N Kirby, T Hanley, BJ Boyd
International journal of pharmaceutics 421 (1), 176-182, 2011
2202011
Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs
KWY Lee, TH Nguyen, T Hanley, BJ Boyd
International journal of pharmaceutics 365 (1-2), 190-199, 2009
2192009
Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected …
GA Kossena, BJ Boyd, CJH Porter, WN Charman
Journal of pharmaceutical sciences 92 (3), 634-648, 2003
2182003
An overview of 3D printing technologies for soft materials and potential opportunities for lipid-based drug delivery systems
K Vithani, A Goyanes, V Jannin, AW Basit, S Gaisford, BJ Boyd
Pharmaceutical research 36, 1-20, 2019
2172019
Drug release from nanomedicines: selection of appropriate encapsulation and release methodology
SJ Wallace, J Li, RL Nation, BJ Boyd
Drug delivery and translational research 2, 284-292, 2012
2142012
Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration
TH Nguyen, T Hanley, CJH Porter, BJ Boyd
Journal of controlled release 153 (2), 180-186, 2011
2122011
Steric stabilisation of self-assembled cubic lyotropic liquid crystalline nanoparticles: high throughput evaluation of triblock polyethylene oxide-polypropylene oxide …
JYT Chong, X Mulet, LJ Waddington, BJ Boyd, CJ Drummond
Soft Matter 7 (10), 4768-4777, 2011
2062011
Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38
V Bala, S Rao, BJ Boyd, CA Prestidge
Journal of controlled release 172 (1), 48-61, 2013
2052013
Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties
LM Kaminskas, BJ Boyd, CJH Porter
Nanomedicine 6 (6), 1063-1084, 2011
2042011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20